ROSELINE CARELUS: Open Payments
NPI 1760699060 · FREEPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 26 payments from 8 companies in 2025. Trend: 2023 $234 · 2024 $860 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $509 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $276 |
| Novo Nordisk Inc | 4 | $179 |
| Eisai Inc. | 2 | $148 |
| Mannkind Corporation | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| Renalytix AI, Inc. | 1 | $20 |
Products named: Kerendia, AIRSUPRA, Ozempic, Leqembi, BREZTRI, FARXIGA, AFREZZA, GARDASIL 9.
Industry payments across NY — which companies pay providers there.
